Charles River - JP Morgan Conference Presentation
Broad capabilities across all modalities
Accelerating discovery to clinical candidate & beyond
Modality
Spectrum of Capabilities
Small
Discovery
Non-Clinical Development
Molecule
Early discovery and disease biology
capabilities across major therapeutic
areas to develop innovative small
molecule candidates
Acquisitions
Cerpen
argenta BioFocus
Large Molecule/
Non-Clinical Development
Discovery
Antibodies
+
Biologics QC Testing
Antibody libraries and integrated
antibody optimization technologies to
provide fully integrated antibody drug
discovery services
distributed bio
algorithms for life
Non-Clinical Development
Cell & Gene
Therapy
Discovery
+
Biologics QC Testing
+
Clinical/Commercial Production
Cellular products, efficacy and safety
testing, process development, analytical
testing, and CDMO solutions to support
clients through commercial production
of advanced drug modalities
ā
Charles River - JP Morgan Conference Presentation
COGNATE
BIOSERVICES
A Charles River Company
Vigene Biosciences
Excellence in Gene Delivery
16View entire presentation